Gemzar®(Ci) and epirubicin (E) in patients (pts) with metastatic breast cancer(MBC):: Final results of a phase I dose finding study

被引：0
|
作者：
Fumoleau, P
Viens, P
Dieras, V
Pujade-Lauraine, E
Espie, M
Kayitalire, L
Rongier, AM
Pouillart, P
机构：
[1] Ctr Rene Gauducheau, F-44035 Nantes, France
[2] Inst J Paoli I Calmettes, F-13009 Marseille, France
[3] Inst Curie, Paris, France
[4] Hop St Louis, Paris, France
[5] Hotel Dieu, Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1173
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [31] Multicenter, non-randomized phase II study with RPR109881 in taxane-exposed metastatic breast cancer (MBC) patients (pts): Final results.
    Dieras, V
    Valero, V
    Limentani, S
    Romieu, G
    Tubiana-Hulin, M
    Lortholary, A
    Ferrero, JM
    Kaufman, P
    Buchbinder, A
    Besenval, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 20S - 20S
  • [32] A phase II study of the prateasome inhibitor PS-341 in patients (pts) with metastatic breast cancer (MBC)
    Brown, J
    Von Roenn, J
    O'Regan, R
    Bergan, R
    Badve, S
    Rademaker, A
    Feehan, S
    Petersen, J
    Patton, M
    Gradishar, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 14S - 14S
  • [33] A phase II study of biweekly pemetrexed (PEM) and gemcitabine (GEM) in patients (PTS) with metastatic breast cancer (MBC)
    Dent, Susan F.
    Gertler, Stan
    Verma, Shailendra
    Segal, Roanne
    Young, Vince
    Haq, Anwar
    Goel, Rakesh
    Keller, Oliver
    Canil, Christina
    Iscoe, Neill
    ANNALS OF ONCOLOGY, 2006, 17 : 85 - 86
  • [34] Sequential administration of docetaxel (D) (Taxotere™) followed by AC in first line metastatic breast cancer (MBC) patients (pts):: Final results
    Antoine, EC
    Chollet, P
    Monfardini, S
    Sorio, R
    Ambrosini, G
    Benhammouda, A
    Mazen, MF
    Ramazeilles, C
    Azli, N
    Khayat, D
    ANNALS OF ONCOLOGY, 1998, 9 : 19 - 20
  • [35] Randomized phase III study of epirubicin (E) versus gemcitabine (G) chemotherapy in elderly females with metastatic breast cancer (MBC)
    Feher, O
    Vodvarka, P
    Jassem, J
    Morack, G
    Advani, SH
    Khoo, KS
    Doval, D
    von Minckwitz, G
    Jungnelius, U
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S66
  • [36] A Phase II Trial of Ganetespib: Efficacy and Safety in Patients (pts) with Metastatic Breast Cancer (MBC)
    Jhaveri, K.
    Chandarlapaty, S.
    Lake, D.
    Gilewski, T.
    Drullinsky, P.
    Sugarman, S.
    Wasserheit-Leiblich, C.
    Moynahan, M. E.
    D'Andrea, G.
    Haque, S.
    Patil, S.
    Bauman, L.
    Vukovic, V.
    El-Hariry, I.
    Hudis, C.
    Modi, S.
    CANCER RESEARCH, 2011, 71
  • [37] Phase I dose finding study of high dose vinorelbine (VNR), mitoxantrone (MTX) and cyclophosphamide (C) with bone marrow support in metastatic breast cancer (MBC)
    Nabholtz, JM
    Stewart, D
    AlTweigeri, T
    Moquin, JP
    Machey, JR
    Smylie, M
    Keller, O
    Sansregret, E
    Au, D
    Follett, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 679 - 679
  • [38] A phase I study of diethylnorspermine (DENSPM) in previously treated patients with metastatic breast cancer (MBC).
    Wolff, AC
    Bowling, MK
    DeClue, C
    Armstrong, DK
    Fetting, JH
    Casero, RA
    Davidson, NE
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 286 - 286
  • [39] Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study
    Redaelli, A
    Baldini, E
    Salvadori, B
    Aldrighetti, D
    Conte, PF
    Quattrocchio, M
    Svanosio, M
    Bergamino, T
    Tibaldi, C
    Lionetto, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S320 - S320
  • [40] Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study
    Redaelli, A
    Baldini, E
    Salvadori, B
    Conte, PF
    Carnino, F
    Guarneri, M
    Svanosio, M
    Dongiovanni, P
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S90 - S90
12345